Two-Year Clinical Outcomes of Paclitaxel-Eluting Stents for In-Stent Restenosis in Patients From the ARRIVE Programme

Authors

Michael S. LeeFollow
Tae YangFollow
John M. Lasala MD, PhDFollow
David A. Cox MD, Lehigh Valley Health NetworkFollow
Thomas S. Bowman MD, MPHFollow
Ruth M. Starzyk PhDFollow
Keith D. Dawkins MDFollow

Publication/Presentation Date

7-2011

Volume

7

Issue

3

Published In/Presented At

Lee, M., Yang, T., Lasala, J., Cox, D., Bowman, T., Starzyk, R., & Dawkins, K. (2011). Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme. Eurointervention: Journal Of Europcr In Collaboration With The Working Group On Interventional Cardiology Of The European Society Of Cardiology, 7(3), 314-322. doi:10.4244/EIJV7I3A55

Disciplines

Cardiology | Medical Sciences | Medical Specialties | Medicine and Health Sciences

PubMedID

21729833

LVHN link

http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=21729833&site=ehost-live&scope=site

Department(s)

Department of Medicine, Cardiology Division

Document Type

Article